The U.S. cannabis industry continued to expand in 2024, but growth was far from uniform. Some emerging markets recorded sharp sales increases, while several mature markets experienced declining revenue and intensifying price pressure.

Based on sales activity reported during the year, 11 state cannabis markets were projected to generate more than $1 billion in annual sales. California remained the country’s largest market, while Michigan continued to close the gap. Medical-only markets such as Florida and Pennsylvania also demonstrated considerable economic scale.

This state-by-state review examines the billion-dollar cannabis markets projected for 2024 and the broader lessons they offered cannabis operators.

Editor’s note: The figures below are projections published during 2024, not current market estimates. Most were calculated from monthly state sales data available at the time. Final year-end results varied, and regulatory conditions have continued to change.

The Billion-Dollar Cannabis Markets of 2024

The following 11 states were projected to exceed $1 billion in annual cannabis sales, according to a Cannabis Business Times analysis.

Figures have been rounded for readability. Florida’s projection came from an external market estimate because the state did not publish comparable retail sales totals.

California Remained the Largest Cannabis Market

California was projected to generate approximately $4.72 billion in cannabis sales during 2024. That placed it comfortably ahead of every other state market.

However, the forecast also represented a 3.4% decline from 2023. Later reporting placed California’s final 2024 sales at approximately $4.66 billion, reinforcing the challenges facing the mature market.

High operating costs, local restrictions, taxes, price compression, and competition from unlicensed sellers continued to affect licensed businesses. California showed that a large market does not automatically produce favorable conditions for every operator.

Michigan Continued to Gain Ground

Michigan was projected to generate approximately $3.32 billion, representing an 8.6% increase from the previous year.

Competitive pricing and broad retail access helped support sales volume. However, those same conditions created intense competition among retailers and producers.

Later data placed Michigan’s final annual sales at approximately $3.03 billion. Although this was below the original projection, the state still maintained its position as one of the country’s largest cannabis markets.

Michigan demonstrated how accessible retail networks and lower prices can encourage consumer participation. It also illustrated the margin pressure businesses may face in a highly competitive environment.

Florida Demonstrated the Scale of Medical Cannabis

Florida was projected to generate approximately $2.15 billion in medical cannabis sales during 2024. This estimate would have placed the state ahead of several established adult-use markets.

Unlike most states on the list, Florida had not legalized adult-use sales. Its market was supported by a large population, extensive medical-patient participation, and an expanding dispensary network.

The projection was based on third-party research rather than official state sales reports, so it should not be treated as a directly comparable government figure. Still, Florida illustrated how a large medical-only program can support substantial commercial activity.

Illinois Approached $2 Billion

Illinois was projected to produce nearly $2 billion in sales during 2024. Final reporting later placed the market slightly above that threshold at approximately $2.01 billion.

Sales continued growing, although at a slower rate than in newer adult-use markets. Illinois also maintained relatively high retail prices, which increased revenue but could encourage some consumers to purchase from neighboring markets or unlicensed sellers.

For operators, Illinois highlighted the importance of balancing market expansion with consumer accessibility and competitive pricing.

Massachusetts Entered a More Mature Phase

The Massachusetts cannabis market was projected to generate approximately $1.80 billion in 2024, representing almost no annual growth.

Final sales were closer to $1.67 billion. The difference showed why midyear projections should be treated cautiously, particularly in mature markets affected by falling prices and changing consumer behavior.

Massachusetts remained a substantial market, but slower growth suggested that operators could no longer depend on industry expansion alone. Efficiency, customer retention, and brand differentiation became increasingly important.

Pennsylvania’s Medical Market Continued Growing

Pennsylvania was projected to generate approximately $1.67 billion in medical cannabis sales, an increase of 9.4%.

Like Florida, Pennsylvania demonstrated the economic potential of a large medical-only program. Its population and established patient base supported continued growth even without adult-use sales.

The state has also remained an important market to watch for potential legalization. Any transition to adult-use retail could create new opportunities, although the timing and structure of reform remain subject to the legislative process.

Missouri Benefited From Adult-Use Expansion

Missouri was projected to produce approximately $1.44 billion in cannabis sales during 2024.

Adult-use sales began in February 2023, giving the state a relatively fast path into the billion-dollar market. Missouri benefited from an existing medical infrastructure, strong early demand, and consumers from neighboring states with more restrictive cannabis laws.

Its growth showed how quickly a newly launched adult-use market can expand when retail infrastructure is already in place.

Colorado, Arizona, and Washington Faced Declining Sales

Three established Western markets were projected to remain above $1 billion while recording annual declines.

Colorado was projected to generate approximately $1.41 billion, an 8% decline. Arizona was expected to reach $1.34 billion, down 7.5%, while Washington was projected to generate approximately $1.20 billion, a decline of 3.3%.

These states faced many of the conditions associated with mature cannabis markets, including oversupply, falling prices, intense competition, and slower customer growth.

Their results reinforced an important lesson: market size and business profitability are not the same thing. Operators still need effective cost controls, differentiated products, reliable technology, and strong customer relationships.

Maryland Recorded the Fastest Projected Growth

Maryland was projected to generate approximately $1.13 billion in sales, representing a 43.8% annual increase.

Adult-use sales began in July 2023, making 2024 the state’s first full calendar year with recreational retail. Its rapid growth reflected the initial surge that often follows the launch of an adult-use market.

Maryland’s experience also showed the value of building adult-use sales on top of existing medical infrastructure. Established stores, supply chains, and regulatory systems can help a market scale more quickly.

New Jersey Was Closer Than Forecasts Suggested

New Jersey was initially projected to generate approximately $959 million, leaving it just outside the group of billion-dollar markets.

However, year-end reporting based on state regulatory data showed that New Jersey ultimately surpassed $1 billion in combined cannabis sales during 2024.

This result illustrates the limitations of annualizing incomplete monthly data. Rapidly growing markets can outperform projections as retailers open, product access improves, and consumer participation increases.

What the 2024 Results Revealed

The 2024 market landscape showed that cannabis growth was becoming increasingly dependent on local conditions.

Newer adult-use markets such as Maryland and Missouri benefited from expanding access and strong initial demand. Medical-only states such as Florida and Pennsylvania demonstrated that large patient populations can support substantial markets without recreational sales.

Meanwhile, established markets including California, Colorado, Arizona, and Washington faced declining sales despite their size. Oversupply, pricing pressure, taxes, regulatory costs, and competition from unlicensed sellers continued to influence performance.

For cannabis businesses, entering a billion-dollar market does not guarantee success. Operators must evaluate local licensing conditions, customer demand, store density, taxation, payment access, and competitive intensity.

Payment Infrastructure in Expanding Cannabis Markets

As state cannabis markets grow, retailers need payment infrastructure that can support higher transaction volumes without creating unnecessary friction.

Cash remains common throughout cannabis retail, but relying on it exclusively creates security, reconciliation, and customer-experience challenges. Digital debit, ACH, eCheck, and other compliant solutions can help dispensaries offer greater flexibility while reducing their dependence on cash.

Payment redundancy is also important. Regulatory requirements, processor policies, and banking relationships can change, leaving retailers vulnerable if every transaction relies on one provider or payment method.

PayRio works with cannabis businesses in established and emerging markets to implement payment solutions designed around the industry’s operational and compliance requirements. Learn more about the markets we support on our cannabis market resources page.

Conclusion

The billion-dollar cannabis markets of 2024 represented very different stages of industry development.

California remained the largest market but continued to contract. Michigan gained ground through strong sales volume and competitive pricing. Maryland experienced rapid growth after launching adult-use sales, while Florida and Pennsylvania demonstrated the scale of medical cannabis demand.

These differences show why operators should look beyond headline revenue figures. Sustainable success depends on local regulations, competitive conditions, operating efficiency, customer experience, and reliable financial infrastructure.

If your cannabis business needs a payment strategy designed for a regulated market, contact PayRio to discuss available solutions.